Form D · Biotechnology

Edison Pharmaceuticals Inc

Mountain View, CA · CIK 0001346136

Offering snapshot reported Mar 27, 2014 · SEC filing

Reported sold
$50M
Offering amount: $100M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 20, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 27, 2014Initial$50,000,135No comparison1SEC filing
Nov 26, 2012Initial$20,049,916No comparison6SEC filing
Aug 31, 2011Initial$4,082,386No comparison4SEC filing
Aug 25, 2010Initial$250,026No comparison1SEC filing
Apr 15, 2010Initial$3,024,907No comparison6SEC filing
Apr 23, 2009Initial$2,753,514No comparisonNot reportedSEC filing
Jun 11, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Nov 30, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-214377

Source: Form D, filed Mar 27, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Paul Avery Director
Carl Berg Director
Isaac Cheng Director
Taro Inaba Director
Guy Miller Director, Executive
Forrest Sawyer Director
Martin Thoolen Director
Martine Thoolen Executive
Keith Tsukimura Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
350 No. Bernardo Ave.
Mountain View, CA, 94043